Producers in Injection Pen Market Aimed toward Enhancing Diabetes Care to Propel Fixed Design...
ALBANY, NY, May 10, 2021 / PRNewswire / - Injection pens have become the standard for self-administered insulin therapy for type 1 and type...
FDA greenlights Bigfoot Biomedical’s insulin recommending diabetes administration system
This morning Bigfoot Biomedical announced that it has received FDA 510 (k) clearance for its Bigfoot Unity Diabetes Management System.
The system has been approved...
Mylan Loses Tribunal Problem to Merck Diabetes Remedy Patent
Merck Sharp & Dohme Corp. fought a patent office challenge filed by Mylan Pharmaceuticals Inc. and other generic drug makers for a patent...
Charlyn Fargo Ware: Find out how to Make a Way of life Change to...
Statistics say that one in three adults in the US is currently at risk for developing type 2 diabetes. The...
Scientists develop understanding of muscle losing In type-2 diabetes
HOLLYWOOD, Fla. - A new study examines the link between muscle weakness and type 2 diabetes and finds that a gene responsible for muscle...
Drug goal pathway may unlock therapies for diabetes, most cancers and COVID – UQ...
Scientists have visualized and investigated an important molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases, and possibly even COVID-19.
The...
Our analysis exhibits gaps in South Africa’s diabetes administration programme
Diabetes is currently the ninth leading cause of death worldwide. Around 420 million people or 6% of the world population are affected. ...
Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Administration System, That includes First-of-its-Variety...
MILPITAS, California - (BUSINESS WIRE) - Bigfoot Biomedical, a company committed to improving health outcomes for...